Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The Melkersson-Rosenthal syndrome is a rare disorder characterized by a triad of recurrent orofacial swelling, relapsing facial paralysis and fissured tongue and onset in childhood or early adolescence. It has an estimated incidence of 8/10,000. The etiology is unknown but hereditary predisposition is suspected.
Features include: Facial palsy, Furrowed tongue, Facial edema, and Abnormality of the eye.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 2 | Facial palsy, Facial edema |
Eyes |
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for Melkersson-Rosenthal syndrome.
30 publications have been identified in PubMed for Melkersson-Rosenthal syndrome. Research spans Case Report / Case Series (80%), Review / Meta-Analysis (13%), and Other (7%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 24 | 80% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 4:49 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Melkersson-Rosenthal syndrome
Abnormality of the eye |
4 |
13% |
Other research | 2 | 7% |
Garg A (2026). [PMID: 42213578](https://pubmed.ncbi.nlm.nih.gov/42213578/). *QJM*. [Review / Meta-Analysis]
Bolzon A (2026). [PMID: 41327959](https://pubmed.ncbi.nlm.nih.gov/41327959/). *Ital J Dermatol Venerol*. [Review / Meta-Analysis]
Bolzon A (2026). [PMID: 41410388](https://pubmed.ncbi.nlm.nih.gov/41410388/). *Ital J Dermatol Venerol*. [Review / Meta-Analysis]
Turpin DB (2026). [PMID: 41685102](https://pubmed.ncbi.nlm.nih.gov/41685102/). *JAAD Case Rep*. [Case Report / Case Series]
Sánchez Vázquez AT (2026). [PMID: 41561388](https://pubmed.ncbi.nlm.nih.gov/41561388/). *Med Int (Lond)*. [Case Report / Case Series]
Correia FA (2026). [PMID: 41913836](https://pubmed.ncbi.nlm.nih.gov/41913836/). *Cureus*. [Case Report / Case Series]
El Feghaly C (2026). [PMID: 41959944](https://pubmed.ncbi.nlm.nih.gov/41959944/). *Plast Reconstr Surg Glob Open*. [Case Report / Case Series]
Kitakaze K (2026). [PMID: 41589051](https://pubmed.ncbi.nlm.nih.gov/41589051/). *J Dermatol*. [Other]
Singh AP (2026). [PMID: 41371249](https://pubmed.ncbi.nlm.nih.gov/41371249/). *J Cutan Pathol*. [Case Report / Case Series]
Minocha A (2026). [PMID: 41481502](https://pubmed.ncbi.nlm.nih.gov/41481502/). *Eur J Ophthalmol*. [Case Report / Case Series]
AI-curated news mentioning Melkersson-Rosenthal syndrome
Updated Aug 21, 2026
A recent case report and systematic review highlight the challenges in managing Melkersson-Rosenthal syndrome, emphasizing the need for improved treatment strategies. This research contributes to the understanding of this rare condition and its complexities.
A case study highlights the successful treatment of Melkersson-Rosenthal syndrome in an allergic patient using fresh frozen plasma. This approach may offer new insights into therapeutic options for this rare condition.